Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002621979 | SCV002966562 | uncertain significance | not provided | 2022-03-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with WDR62-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 496 of the WDR62 protein (p.Arg496Gln). |
Institute of Human Genetics, |
RCV003493966 | SCV004242491 | likely pathogenic | Microcephaly 2, primary, autosomal recessive, with or without cortical malformations | 2024-07-05 | criteria provided, single submitter | clinical testing | Criteria applied: PM2,PM5, PM3 |